<DOC>
	<DOCNO>NCT00355498</DOCNO>
	<brief_summary>Amyloid senile plaque ( SPs ) neurofibrillary tangle ( NFTs ) neuropathological hallmark Alzheimer 's disease ( AD ) also accumulate key brain region association normal age . This project expand establish program early detection prevention AD design ( 1 ) identify presymptomatic person likely benefit early intervention ( 2 ) provide objective , noninvasive mean monitor therapeutic trial .</brief_summary>
	<brief_title>Amyloid Plaque Tangle Imaging Aging Dementia</brief_title>
	<detailed_description>A total 194 volunteer recruit 2-year study . Participants receive baseline clinical image evaluation one follow-up evaluation two year later . These evaluation include clinical neuropsychological assessment , structural MRI and/or PET scan . Additional scan scan procedure perform subset participant participant visit , include serotonin density level .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<mesh_term>Plaque , Amyloid</mesh_term>
	<criteria>Agreement participate clinical brain imaging study Age 30 year old No significant cerebrovascular disease modify Ischemic Score ≤ 4 For volunteer MCI dementia , must family member potential caregiver available Adequate visual auditory acuity allow neuropsychological test Screening laboratory test ECG without significant abnormality might interfere study . Evidence neurologic physical illness could produce cognitive deterioration ; addition physical neurological examination , volunteer screen Parkinson 's disease History myocardial infarction within previous year unstable cardiac disease Uncontrolled hypertension ( systolic BP &gt; 170 diastolic BP &gt; 100 ) , history significant liver disease , clinically significant pulmonary disease , diabetes , cancer Major psychiatric disorder , bipolar disorder schizophrenia Because medication affect cognitive functioning , volunteer need medicine could influence psychometric test result exclude ; use follow drug also exclude volunteer : centrally active betablockers , narcotic , clonidine , antiParkinsonian medication , benzodiazepine , systemic corticosteroid , medication significant cholinergic anticholinergic effect , anticonvulsant , warfarin Current diagnosis history alcoholism drug dependence Evidence untreated depression determine HAMD ( Hamilton , 1960 ) score ≥ 12 ( 17item version ) untreated anxiety score ≥ 8 Hamilton Anxiety Scale ( HAMA ; Hamilton , 1959 ) Use investigational drug within previous month longer , depend drug halflife Contraindication MRI scan ( e.g. , metal body , claustrophobia )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>functional magnetic resonance imaging</keyword>
	<keyword>positron emission tomography</keyword>
	<keyword>beta-amyloid</keyword>
	<keyword>tau</keyword>
</DOC>